Bivalent OX40 Aptamer and CpG as Dual Agonists for Cancer Immunotherapy
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.4c18550 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Tingting Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Receptors, OX40, Immunotherapy, Oligodeoxyribonucleotides. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
- Department of Hematology-Oncology, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 400030, China.
- Department of Oncology, The Ninth People's Hospital of Chongqing, Chongqing 400700, China.
- Department of Chemistry, Purdue University, West Lafayette 47907, Indiana, United States.
ORCID-Profile: Tingting Jiang, Liang Fang, Chengde Mao, Cheng Zhi Huang, Hua Zuo
Förderung
- Natural Science Foundation of Chongqing Municipality
- National Natural Science Foundation of China
Zitieren
APA
Jiang, T., Yang, Z., Su, Q., Fang, L., Xiang, Q., Tian, C., Gao, Q., Mao, C., Huang, C. Z., & Zuo, H. (2025). Bivalent OX40 Aptamer and CpG as Dual Agonists for Cancer Immunotherapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c18550
Vancouver
Jiang T, Yang Z, Su Q, Fang L, Xiang Q, Tian C, et al. Bivalent OX40 Aptamer and CpG as Dual Agonists for Cancer Immunotherapy. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c18550
BibTeX
@article{Jiang2025,
author = {Jiang, Tingting and Yang, Zailin and Su, Qiuyu and Fang, Liang and Xiang, Qing and Tian, Cheng and Gao, Qinlin and Mao, Chengde and Huang, Cheng Zhi and Zuo, Hua},
title = {Bivalent OX40 Aptamer and CpG as Dual Agonists for Cancer Immunotherapy},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.4c18550}
}
EUVIMED